Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies
Primary sarcopenia is characterized by a progressive loss of skeletal muscle mass, strength, and physical function that occurs with aging. Despite the related adverse or even serious health outcomes, no medications are currently available for treating primary sarcopenia. Here, we discuss recent adva...
Saved in:
Main Authors: | Wei Yang, Si-Cong Si, Wei-Hua Wang, Jing Li, Yi-Xin Ma, Huan Zhao, Jia Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1526764/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis
by: Guangning Wang, et al.
Published: (2025-01-01) -
The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis
by: Ruyi Zhang, et al.
Published: (2025-01-01) -
The Role of Gut Microbiota in Hypertension Management - A Review
by: Alicja Kot, et al.
Published: (2025-02-01) -
Development of an artificial intelligence-based application for the diagnosis of sarcopenia: a retrospective cohort study using the health examination dataset
by: Chang-Won Jeong, et al.
Published: (2025-02-01) -
Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle
by: Dhouha Gaida, et al.
Published: (2025-01-01)